The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Unconventional T Cell Targets for Cancer Immunotherapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237 · cited 1×
“Moreover, as one of the key resistance genes associated with checkpoint blockade therapy is β 2M (Zaretsky et al., 2016) which is associated with MHC class-Ia, MHC class-Ib, MR1 and CD1 family members, studies into the role that each of these T cell lineages play in this therapy is warranted.”
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,118
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
Morales, A., Eidinger, D., & Bruce, A. W. (1976) · Journal of Urology · doi:10.1016/s0022-5347(17)58737-6 · Cited by 1,791
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
Morales, A., Eidinger, D., & Bruce, A. W. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.101 · Cited by 1,533
A Class I Antigen, HLA-G, Expressed in Human Trophoblasts
Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J., & DeMars, R. (1990) · Science · doi:10.1126/science.2326636 · Cited by 1,407
MR1 presents microbial vitamin B metabolites to MAIT cells
Kjer-Nielsen, L., Patel, O., Corbett, A. J., Le Nours, J., Meehan, B., Liu, L., Bhati, M., Chen, Z., Kostenko, L., Reantragoon, R., et al. (2012) · Nature · doi:10.1038/nature11605 · Cited by 1,351
Self-citationSix-of-the-best: unique contributions of γδ T cells to immunology
Vantourout, P., & Hayday, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3384 · Cited by 1,232 · cited 1×
“There is only limited knowledge about their Ag reactivity, although some can react with MHC-I like molecules such as MICA, CD1 and EPCR, or soluble Ags in the absence of Ag-presentation, in sharp contrast to other types of T cells (reviewed in (Godfrey et al., 2015; Vantourout and Hayday, 2013)).”
Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J., & Kaer, L. V. (2004) · Nature Reviews Immunology · doi:10.1038/nri1309 · Cited by 1,182
Self-citationSelection of evolutionarily conserved mucosal-associated invariant T cells by MR1
Treiner, E., Duban, L., Bahram, S., Radosavljevic, M., Wanner, V., Tilloy, F., Affaticati, P., Gilfillan, S., & Lantz, O. (2003) · Nature · doi:10.1038/nature01433 · Cited by 1,139
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17–secreting T cells
Dusseaux, M., Martin, E., Serriari, N., Péguillet, I., Premel, V., Louis, D., Milder, M., Le Bourhis, L., Soudais, C., Treiner, E., et al. (2011) · Blood · doi:10.1182/blood-2010-08-303339 · Cited by 1,027
Regulation of Cutaneous Malignancy by γδ T Cells
Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, R. E., & Hayday, A. C. (2001) · Science · doi:10.1126/science.1063916 · Cited by 1,004
Intracavitary bacillus Calmette-Grerin in the treatement of superficial bladder tumors
Morales, A. (1976) · The Journal of Urology · Cited by 978
Antimicrobial activity of mucosal-associated invariant T cells
Le Bourhis, L., Martin, E., Péguillet, I., Guihot, A., Froux, N., Coré, M., Lévy, E., Dusseaux, M., Meyssonnier, V., Premel, V., et al. (2010) · Nature Immunology · doi:10.1038/ni.1890 · Cited by 936
T-cell activation by transitory neo-antigens derived from distinct microbial pathways
Corbett, A. J., Eckle, S. B. G., Birkinshaw, R. W., Liu, L., Patel, O., Mahony, J., Chen, Z., Reantragoon, R., Meehan, B., Cao, H., et al. (2014) · Nature · doi:10.1038/nature13160 · Cited by 878
Self-citationGoing both ways: Immune regulation via CD1d-dependent NKT cells
Godfrey, D. I., & Kronenberg, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423594 · Cited by 877
Self-citationMore than one reason to rethink the use of peptides in vaccine design
Purcell, A. W., McCluskey, J., & Rossjohn, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2224 · Cited by 860
Self-citationDifferential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829
Self-citationThe burgeoning family of unconventional T cells
Godfrey, D. I., Uldrich, A. P., McCluskey, J., Rossjohn, J., & Moody, D. B. (2015) · Nature Immunology · doi:10.1038/ni.3298 · Cited by 805
Self-citationPorcelli, S., Yockey, C. E., Brenner, M. B., & Balk, S. P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.1 · Cited by 756
The mechanism of action of BCG therapy for bladder cancer--a current perspective
Redelman-Sidi, G., Glickman, M. S., & Bochner, B. H. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.15 · Cited by 729
Fujii, S.-I., Shimizu, K., Smith, C., Bonifaz, L., & Steinman, R. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030324 · Cited by 711
Vaccines for established cancer: overcoming the challenges posed by immune evasion
van der Burg, S. H., Arens, R., Ossendorp, F., van Hall, T., & Melief, C. J. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.16 · Cited by 709
Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells
Gold, M. C., Cerri, S., Smyk-Pearson, S., Cansler, M. E., Vogt, T. M., Delepine, J., Winata, E., Swarbrick, G. M., Chua, W.-J., Yu, Y. Y. L., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000407 · Cited by 673
Kunzmann, V., Bauer, E., Feurle, J., Tony, F. W., & Wilhelm, M. (2000) · Blood · doi:10.1182/blood.v96.2.384 · Cited by 669
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Melero, I., Berman, D. M., Aznar, M. A., Korman, A. J., Gracia, J. L. P., & Haanen, J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3973 · Cited by 637
Tilloy, F., Treiner, E., Park, S.-H., Garcia, C., Lemonnier, F., de la Salle, H., Bendelac, A., Bonneville, M., & Lantz, O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1907 · Cited by 615
Lee, Y. J., Holzapfel, K. L., Zhu, J., Jameson, S. C., & Hogquist, K. A. (2013) · Nature Immunology · doi:10.1038/ni.2731 · Cited by 603
CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor
Borg, N. A., Wun, K. S., Kjer-Nielsen, L., Wilce, M. C. J., Pellicci, D. G., Koh, R., Besra, G. S., Bharadwaj, M., Godfrey, D. I., McCluskey, J., et al. (2007) · Nature · doi:10.1038/nature05907 · Cited by 590
Self-citationReantragoon, R., Corbett, A. J., Sakala, I. G., Gherardin, N. A., Furness, J. B., Chen, Z., Eckle, S. B. G., Uldrich, A. P., Birkinshaw, R. W., Patel, O., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130958 · Cited by 589
Self-citationSilva-Santos, B., Serre, K., & Norell, H. (2015) · Nature reviews. Immunology · doi:10.1038/nri3904 · Cited by 565
Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S. J., Makadzange, A., Rowland-Jones, S., Willcox, B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431057100 · Cited by 557
γδ T cells for immune therapy of patients with lymphoid malignancies
Wilhelm, M., Kunzmann, V., Eckstein, S., Reimer, P., Weissinger, F., Ruediger, T., & Tony, H.-P. (2003) · Blood · doi:10.1182/blood-2002-12-3665 · Cited by 550
MAIT cells are activated during human viral infections
van Wilgenburg, B., Scherwitzl, I., Hutchinson, E. C., Leng, T., Kurioka, A., Kulicke, C., de Lara, C., Cole, S., Vasanawathana, S., Limpitikul, W., et al. (2016) · Nature Communications · doi:10.1038/ncomms11653 · Cited by 509
Giaccone, G., Punt, C. J. A., Ando, Y., Ruijter, R., Nishi, N., Peters, M. E. W. J., Blomberg, B. M. E. V., Scheper, R. J., van der Vliet, H. J., van den Eertwegh, A. J. M., et al. (2002) · PubMed · Cited by 506
Braud, V., Yvonne Jones, E., & McMichael, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270517 · Cited by 502
Dieli, F., Vermijlen, D., Fulfaro, F., Caccamo, N., Meraviglia, S., Cicero, G., Roberts, A., Buccheri, S., D'Asaro, M., Gebbia, N., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0199 · Cited by 497
Hermans, I. F., Silk, J. D., Gileadi, U., Salio, M., Mathew, B., Ritter, G., Schmidt, R., Harris, A. L., Old, L., & Cerundolo, V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5140 · Cited by 492
Vance, R. E., Kraft, J. R., Altman, J. D., Jensen, P. E., & Raulet, D. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1841 · Cited by 482
γδ T cells in homeostasis and host defence of epithelial barrier tissues
Nielsen, M. M., Witherden, D. A., & Havran, W. L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.101 · Cited by 479
Coquet, J. M., Chakravarti, S., Kyparissoudis, K., McNab, F. W., Pitt, L. A., McKenzie, B. S., Berzins, S. P., Smyth, M. J., & Godfrey, D. I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801631105 · Cited by 463
Self-citationγδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity
Gao, Y., Yang, W., Pan, M., Scully, E., Girardi, M., Augenlicht, L. H., Craft, J., & Yin, Z. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030584 · Cited by 453
Chang, D. H., Osman, K., Connolly, J., Kukreja, A., Krasovsky, J., Pack, M., Hutchinson, A., Geller, M., Liu, N., Annable, R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042592 · Cited by 415
Peng, G., Wang, H. Y., Peng, W., Kiniwa, Y., Seo, K. H., & Wang, R.-F. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.020 · Cited by 408
Ishikawa, A., Motohashi, S., Ishikawa, E., Fuchida, H., Higashino, K., Otsuji, M., Iizasa, T., Nakayama, T., Taniguchi, M., & Fujisawa, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1453 · Cited by 403
Carosella, E. D., Rouas-Freiss, N., Roux, D. T.-L., Moreau, P., & LeMaoult, J. (2015) · Advances in Immunology · doi:10.1016/bs.ai.2015.04.001 · Cited by 395
The crystal structure of human CD1d with and without α-galactosylceramide
Koch, M., Stronge, V. S., Shepherd, D., Gadola, S. D., Mathew, B., Ritter, G., Fersht, A. R., Besra, G. S., Schmidt, R. R., Jones, E. Y., et al. (2005) · Nature Immunology · doi:10.1038/ni1225 · Cited by 395
Smyth, M. J., Crowe, N. Y., Pellicci, D. G., Kyparissoudis, K., Kelly, J. M., Takeda, K., Yagita, H., & Godfrey, D. I. (2002) · Blood · doi:10.1182/blood.v99.4.1259 · Cited by 392
Self-citationHuman trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule.
Ellis, S. A., Palmer, M. S., & McMichael, A. J. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.731 · Cited by 391
Schmieg, J., Yang, G., Franck, R. W., & Tsuji, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031192 · Cited by 385
Rahimpour, A., Koay, H. F., Enders, A., Clanchy, R., Eckle, S. B. G., Meehan, B., Chen, Z., Whittle, B., Liu, L., Fairlie, D. P., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142110 · Cited by 383
Self-citationA three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage
Koay, H.-F., Gherardin, N. A., Enders, A., Loh, L., Mackay, L. K., Almeida, C. F., Russ, B. E., Nold-Petry, C. A., Nold, M. F., Bedoui, S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3565 · Cited by 377
Self-citationKRN7000, a novel immunomodulator, and its antitumor activities.
Kobayashi, E., Motoki, K., Uchida, T., Fukushima, H., & Koezuka, Y. (1995) · PubMed · Cited by 361
Meierovics, A., Yankelevich, W.-J. C., & Cowley, S. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302799110 · Cited by 361
Nieda, M., Okai, M., Tazbirkova, A., Lin, H., Yamaura, A., Ide, K., Abraham, R., Juji, T., Macfarlane, D. J., & Nicol, A. J. (2004) · Blood · doi:10.1182/blood-2003-04-1155 · Cited by 361
IL-7 Licenses Activation of Human Liver Intrasinusoidal Mucosal-Associated Invariant T Cells
Tang, X.-Z., Jo, J., Tan, A. T., Sandalova, E., Chia, A., Tan, K. C., Lee, K. H., Gehring, A. J., De Libero, G., & Bertoletti, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203218 · Cited by 356
Metelitsa, L. S., Naidenko, O. V., Kant, A., Wu, H.-W., Loza, M. J., Perussia, B., Kronenberg, M., & Seeger, R. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3114 · Cited by 355
De Santo, C., Salio, M., Masri, S. H., Lee, L. Y.-H., Dong, T., Speak, A. O., Porubsky, S., Booth, S., Veerapen, N., Besra, G. S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36264 · Cited by 350
Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Song, L., Asgharzadeh, S., Salo, J., Engell, K., Wu, H.-W., Sposto, R., Ara, T., Silverman, A. M., DeClerck, Y. A., Seeger, R. C., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37869 · Cited by 342
Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
Ma, Y., Aymeric, L., Locher, C., Mattarollo, S. R., Delahaye, N. F., Pereira, P., Boucontet, L., Apetoh, L., Ghiringhelli, F., Casares, N., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100269 · Cited by 337
MHC class Ib molecules bridge innate and acquired immunity
Rodgers, J. R., & Cook, R. G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1635 · Cited by 323
Willcox, C. R., Pitard, V., Netzer, S., Couzi, L., Salim, M., Silberzahn, T., Moreau, J.-F., Hayday, A. C., Willcox, B. E., & Déchanet-Merville, J. (2012) · Nature Immunology · doi:10.1038/ni.2394 · Cited by 321
CD1d-lipid antigen recognition by the γδ TCR
Uldrich, A. P., Le Nours, J., Pellicci, D. G., Gherardin, N. A., McPherson, K. G., Lim, R. T., Patel, O., Beddoe, T., Gras, S., Rossjohn, J., et al. (2013) · Nature Immunology · doi:10.1038/ni.2713 · Cited by 318
Self-citationHeczey, A., Liu, D., Tian, G., Courtney, A. N., Wei, J., Marinova, E., Gao, X., Guo, L., Yvon, E., Hicks, J., et al. (2014) · Blood · doi:10.1182/blood-2013-11-541235 · Cited by 318
Eckle, S. B. G., Birkinshaw, R. W., Kostenko, L., Corbett, A. J., McWilliam, H. E. G., Reantragoon, R., Chen, Z., Gherardin, N. A., Beddoe, T., Liu, L., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140484 · Cited by 318
Self-citationMucosal-associated invariant T cell alterations in obese and type 2 diabetic patients
Magalhaes, I., Pingris, K., Poitou, C., Bessoles, S., Venteclef, N., Kiaf, B., Beaudoin, L., Da Silva, J., Allatif, O., Rossjohn, J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78941 · Cited by 316
Self-citationGodder, K. T., Henslee-Downey, P. J., Mehta, J., Park, B. S., Chiang, K.-Y., Abhyankar, S., & Lamb, L. S. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705650 · Cited by 306
De Santo, C., Arscott, R., Booth, S., Karydis, I., Jones, M., Asher, R., Salio, M., Middleton, M., & Cerundolo, V. (2010) · Nature Immunology · doi:10.1038/ni.1942 · Cited by 304
Recognition of vitamin B metabolites by mucosal-associated invariant T cells
Patel, O., Kjer-Nielsen, L., Le Nours, J., Eckle, S. B. G., Birkinshaw, R., Beddoe, T., Corbett, A. J., Liu, L., Miles, J. J., Meehan, B., et al. (2013) · Nature Communications · doi:10.1038/ncomms3142 · Cited by 301
Self-citationBiology of CD1- and MR1-Restricted T Cells
Salio, M., Silk, J. D., Yvonne Jones, E., & Cerundolo, V. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120243 · Cited by 299
Meraviglia, S., Eberl, M., Vermijlen, D., Todaro, M., Buccheri, S., Cicero, G., La Mendola, C., Guggino, G., D'Asaro, M., Orlando, V, et al. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04167.x · Cited by 295
Tachibana, T., Onodera, H., Tsuruyama, T., Mori, A., Nagayama, S., Hiai, H., & Imamura, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0877 · Cited by 295
HLA-G: At the Interface of Maternal–Fetal Tolerance
Ferreira, L. M. R., Meissner, T. B., Tilburgs, T., & Strominger, J. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.009 · Cited by 291
Terabe, M., Swann, J., Ambrosino, E., Sinha, P., Takaku, S., Hayakawa, Y., Godfrey, D. I., Ostrand-Rosenberg, S., Smyth, M. J., & Berzofsky, J. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051381 · Cited by 283
Self-citationCross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
Wu, D. Y., Segal, N. H., Sidobre, S., Kronenberg, M., & Chapman, P. B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030446 · Cited by 279
Braud, V. M., Allan, D. S. J., Wilson, D., & McMichael, A. J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70014-4 · Cited by 277
Chen, Z., Wang, H., D'Souza, C., Sun, S., Kostenko, L., Eckle, S. B. G., Meehan, B. S., Jackson, D. C., Strugnell, R. A., Cao, H., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.39 · Cited by 275
Self-citationIL-10–producing NKT10 cells are a distinct regulatory invariant NKT cell subset
Sag, D., Krause, P., Hedrick, C. C., Kronenberg, M., & Wingender, G. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72308 · Cited by 274
Human blood MAIT cell subsets defined using MR1 tetramers
Gherardin, N. A., Souter, M. N., Koay, H., Mangas, K. M., Seemann, T., Stinear, T. P., Eckle, S. B., Berzins, S. P., d'Udekem, Y., Konstantinov, I. E., et al. (2018) · Immunology & Cell Biology · doi:10.1111/imcb.12021 · Cited by 267
Self-citationde Kruijf, E. M., Sajet, A., van Nes, J. G. H., Natanov, R., Putter, H., Smit, V. T. H. B. M., Liefers, G. J., van den Elsen, P. J., van de Velde, C. J. H., & Kuppen, P. J. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002629 · Cited by 266
Loh, L., Wang, Z., Sant, S., Koutsakos, M., Jegaskanda, S., Corbett, A. J., Liu, L., Fairlie, D. P., Crowe, J., Rossjohn, J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610750113 · Cited by 265
Self-citationInnate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells
Street, S. E. A., Hayakawa, Y., Zhan, Y., Lew, A. M., MacGregor, D., Jamieson, A. M., Diefenbach, A., Yagita, H., Godfrey, D. I., & Smyth, M. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031981 · Cited by 264
Self-citationProduction of α-Galactosylceramide by a Prominent Member of the Human Gut Microbiota
Wieland Brown, L. C., Penaranda, C., Kashyap, P. C., Williams, B. B., Clardy, J., Kronenberg, M., Sonnenburg, J. L., Comstock, L. E., Bluestone, J. A., & Fischbach, M. A. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001610 · Cited by 257
Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes
Rouxel, O., Da silva, J., Beaudoin, L., Nel, I., Tard, C., Cagninacci, L., Kiaf, B., Oshima, M., Diedisheim, M., Salou, M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3854 · Cited by 253
Self-citationNicol, A. J., Tokuyama, H., Mattarollo, S. R., Hagi, T., Suzuki, K., Yokokawa, K., & Nieda, M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.293 · Cited by 251
Bennouna, J., Bompas, E., Neidhardt, E. M., Rolland, F., Philip, I., Galéa, C., Salot, S., Saiagh, S., Audrain, M., Rimbert, M., et al. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0491-8 · Cited by 249
HLA-E. A novel HLA class I gene expressed in resting T lymphocytes.
Koller, B. H., Geraghty, D. E., Shimizu, Y., DeMars, R., & Orr, H. T. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.897 · Cited by 245
Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1
Garcia-Beltran, W. F., Hölzemer, A., Martrus, G., Chung, A. W., Pacheco, Y., Simoneau, C. R., Rucevic, M., Lamothe-Molina, P. A., Pertel, T., Kim, T.-E., et al. (2016) · Nature Immunology · doi:10.1038/ni.3513 · Cited by 243
Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells
Keller, A. N., Eckle, S. B. G., Xu, W., Liu, L., Hughes, V. A., Mak, J. Y. W., Meehan, B. S., Pediongco, T., Birkinshaw, R. W., Chen, Z., et al. (2017) · Nature Immunology · doi:10.1038/ni.3679 · Cited by 240
Self-citationMotohashi, S., Ishikawa, A., Ishikawa, E., Otsuji, M., Iizasa, T., Hanaoka, H., Shimizu, N., Horiguchi, S., Okamoto, Y., Fujii, S.-I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0114 · Cited by 239
Kobayashi, H., Tanaka, Y., Yagi, J., Osaka, Y., Nakazawa, H., Uchiyama, T., Minato, N., & Toma, H. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0199-6 · Cited by 237
Correia, D. V., Fogli, M., Hudspeth, K., da Silva, M. G., Mavilio, D., & Silva-Santos, B. (2011) · Blood · doi:10.1182/blood-2011-02-339135 · Cited by 236
Semmling, V., Lukacs-Kornek, V., Thaiss, C. A., Quast, T., Hochheiser, K., Panzer, U., Rossjohn, J., Perlmutter, P., Cao, J., Godfrey, D. I., et al. (2010) · Nature Immunology · doi:10.1038/ni.1848 · Cited by 234
Self-citationNatural Killer T Cells in Cancer Immunotherapy
Nair, S., & Dhodapkar, M. V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01178 · Cited by 234
Kain, L., Webb, B., Anderson, B. L., Deng, S., Holt, M., Costanzo, A., Zhao, M., Self, K., Teyton, A., Everett, C., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.017 · Cited by 232
CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire
de Jong, A., Peña-Cruz, V., Cheng, T.-Y., Clark, R. A., Van Rhijn, I., & Moody, D. B. (2010) · Nature Immunology · doi:10.1038/ni.1956 · Cited by 231
Motohashi, S., Nagato, K., Kunii, N., Yamamoto, H., Yamasaki, K., Okita, K., Hanaoka, H., Shimizu, N., Suzuki, M., Yoshino, I., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800126 · Cited by 231
Type II NKT cell–mediated anergy induction in type I NKT cells prevents inflammatory liver disease
Halder, R. C., Aguilera, C., Maricic, I., & Kumar, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31602 · Cited by 226
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+T lymphocytes
Gooden, M., Lampen, M., Jordanova, E. S., Leffers, N., Trimbos, J. B., van der Burg, S. H., Nijman, H., & van Hall, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100354108 · Cited by 215
Pellicci, D. G., Patel, O., Kjer-Nielsen, L., Pang, S. S., Sullivan, L. C., Kyparissoudis, K., Brooks, A. G., Reid, H. H., Gras, S., Lucet, I. S., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.018 · Cited by 215
Self-citationTumor-Infiltrating γδ T Lymphocytes Predict Clinical Outcome in Human Breast Cancer
Ma, C., Zhang, Q., Ye, J., Wang, F., Zhang, Y., Wevers, E., Schwartz, T., Hunborg, P., Varvares, M. A., Hoft, D. F., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201892 · Cited by 214
Gherardin, N. A., Keller, A. N., Woolley, R. E., Le Nours, J., Ritchie, D. S., Neeson, P. J., Birkinshaw, R. W., Eckle, S. B. G., Waddington, J. N., Liu, L., et al. (2016) · Immunity · doi:10.1016/j.immuni.2015.12.005 · Cited by 209
Self-citationAmbrosino, E., Terabe, M., Halder, R. C., Peng, J., Takaku, S., Miyake, S., Yamamura, T., Kumar, V., & Berzofsky, J. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5126 · Cited by 207
Vγ9Vδ2 T Cell Response to Colon Carcinoma Cells
Corvaisier, M., Moreau-Aubry, A., Diez, E., Bennouna, J., Mosnier, J.-F., Scotet, E., Bonneville, M., & Jotereau, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5481 · Cited by 207
Molling, J. W., Langius, J. A. E., Langendijk, J. A., Leemans, C. R., Bontkes, H. J., van der Vliet, H. J. J., von Blomberg, B. M. E., Scheper, R. J., & van den Eertwegh, A. J. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5787 · Cited by 205
Kobayashi, H., Tanaka, Y., Yagi, J., Minato, N., & Tanabe, K. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1021-7 · Cited by 201
A conserved human T cell population targets mycobacterial antigens presented by CD1b
Van Rhijn, I., Kasmar, A., de Jong, A., Gras, S., Bhati, M., Doorenspleet, M. E., de Vries, N., Godfrey, D. I., Altman, J. D., de Jager, W., et al. (2013) · Nature Immunology · doi:10.1038/ni.2630 · Cited by 201
Self-citationPhosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma
Viey, E., Fromont, G., Escudier, B., Morel, Y., Da Rocha, S., Chouaib, S., & Caignard, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1338 · Cited by 192
Zajonc, D. M., Maricic, I., Wu, D., Halder, R., Roy, K., Wong, C.-H., Kumar, V., & Wilson, I. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051625 · Cited by 192
McWilliam, H. E. G., Eckle, S. B. G., Theodossis, A., Liu, L., Chen, Z., Wubben, J. M., Fairlie, D. P., Strugnell, R. A., Mintern, J. D., McCluskey, J., et al. (2016) · Nature Immunology · doi:10.1038/ni.3416 · Cited by 188
Self-citationNakajima, J., Murakawa, T., Fukami, T., Goto, S., Kaneko, T., Yoshida, Y., Takamoto, S., & Kakimi, K. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2009.11.051 · Cited by 186
Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells
Held, W., Roland, J., & Raulet, D. H. (1995) · Nature · doi:10.1038/376355a0 · Cited by 185
Hayakawa, Y., Takeda, K., Yagita∥, H., Kakuta, S., Iwakura, Y., Kaer, L. V., Saiki, I., & Okumura, K. (2001) · PubMed · Cited by 184
Kunii, N., Horiguchi, S., Motohashi, S., Yamamoto, H., Ueno, N., Yamamoto, S., Sakurai, D., Taniguchi, M., Nakayama, T., & Okamoto, Y. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01135.x · Cited by 184
Yamasaki, K., Horiguchi, S., Kurosaki, M., Kunii, N., Nagato, K., Hanaoka, H., Shimizu, N., Ueno, N., Yamamoto, S., Taniguchi, M., et al. (2011) · Clinical Immunology · doi:10.1016/j.clim.2010.11.014 · Cited by 183
Mucosal-associated invariant T cell–rich congenic mouse strain allows functional evaluation
Cui, Y., Franciszkiewicz, K., Mburu, Y. K., Mondot, S., Le Bourhis, L., Premel, V., Martin, E., Kachaner, A., Duban, L., Ingersoll, M. A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82424 · Cited by 179
Abe, Y., Muto, M., Nieda, M., Nakagawa, Y., Nicol, A., Kaneko, T., Goto, S., Yokokawa, K., & Suzuki, K. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.04.008 · Cited by 176
Ling, L., Lin, Y., Zheng, W., Hong, S., Tang, X., Zhao, P., Li, M., Ni, J., Li, C., Wang, L., et al. (2016) · Scientific Reports · doi:10.1038/srep20358 · Cited by 176
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
Silk, J. D., Hermans, I. F., Gileadi, U., Chong, T. W., Shepherd, D., Salio, M., Mathew, B., Schmidt, R. R., Lunt, S. J., Williams, K. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422046 · Cited by 174
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
Tian, G., Courtney, A. N., Jena, B., Heczey, A., Liu, D., Marinova, E., Guo, L., Xu, X., Torikai, H., Mo, Q., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83476 · Cited by 173
Renukaradhya, G. J., Khan, M. A., Vieira, M., Du, W., Gervay-Hague, J., & Brutkiewicz, R. R. (2008) · Blood · doi:10.1182/blood-2007-05-092866 · Cited by 168
Evidence for MR1 Antigen Presentation to Mucosal-associated Invariant T Cells
Huang, S., Gilfillan, S., Cella, M., Miley, M. J., Lantz, O., Lybarger, L., Fremont, D. H., & Hansen, T. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501087200 · Cited by 168
Uchida, T., Horiguchi, S., Tanaka, Y., Yamamoto, H., Kunii, N., Motohashi, S., Taniguchi, M., Nakayama, T., & Okamoto, Y. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-007-0373-5 · Cited by 168
Sakamoto, M., Nakajima, J., Murakawa, T., Fukami, T., Yoshida, Y., Murayama, T., Takamoto, S., Matsushita, H., & Kakimi, K. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318207ecfb · Cited by 168
Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids
Chang, Y.-J., Huang, J.-R., Tsai, Y.-C., Hung, J.-T., Wu, D., Fujio, M., Wong, C.-H., & Yu, A. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703824104 · Cited by 167
Functionally diverse human T cells recognize non-microbial antigens presented by MR1
Lepore, M., Kalinichenko, A., Calogero, S., Kumar, P., Paleja, B., Schmaler, M., Narang, V., Zolezzi, F., Poidinger, M., Mori, L., et al. (2017) · eLife · doi:10.7554/elife.24476 · Cited by 166
Shimizu, K., Kurosawa, Y., Taniguchi, M., Steinman, R. M., & Fujii, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070458 · Cited by 165
Richter, J., Neparidze, N., Zhang, L., Nair, S., Monesmith, T., Sundaram, R., Miesowicz, F., Dhodapkar, K. M., & Dhodapkar, M. V. (2013) · Blood · doi:10.1182/blood-2012-06-435503 · Cited by 164
CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens
de Jong, A., Cheng, T.-Y., Huang, S., Gras, S., Birkinshaw, R. W., Kasmar, A. G., Van Rhijn, I., Peña-Cruz, V., Ruan, D. T., Altman, J. D., et al. (2014) · Nature Immunology · doi:10.1038/ni.2790 · Cited by 161
Self-citationHayakawa, Y., Takeda, K., Yagita, H., Kakuta, S., Iwakura, Y., Van Kaer, L., Saiki, I., & Okumura, K. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200106)31:6<1720::aid-immu1720>3.0.co;2-u · Cited by 161
The Regulatory Role of Invariant NKT Cells in Tumor Immunity
McEwen-Smith, R. M., Salio, M., & Cerundolo, V. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0062 · Cited by 160
Sundström, P., Ahlmanner, F., Akéus, P., Sundquist, M., Alsén, S., Yrlid, U., Börjesson, L., Sjöling, Å., Gustavsson, B. G., Wong, S. B. J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500258 · Cited by 159
Patil, R. S., Shah, S. U., Shrikhande, S. V., Goel, M., Dikshit, R. P., & Chiplunkar, S. V. (2016) · International Journal of Cancer · doi:10.1002/ijc.30134 · Cited by 159
Expression and function of PD‐1 in human γδ T cells that recognize phosphoantigens
Iwasaki, M., Tanaka, Y., Kobayashi, H., Murata‐Hirai, K., Miyabe, H., Sugie, T., Toi, M., & Minato, N. (2011) · European Journal of Immunology · doi:10.1002/eji.201040959 · Cited by 158
Type II NKT Cells and Their Emerging Role in Health and Disease
Dhodapkar, M. V., & Kumar, V. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601399 · Cited by 156
Lang, J. M., Kaikobad, M. R., Wallace, M., Staab, M. J., Horvath, D. L., Wilding, G., Liu, G., Eickhoff, J. C., McNeel, D. G., & Malkovský, M. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1049-8 · Cited by 155
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
Maeurer, M. J., Martin, D., Walter, W., Liu, K., Zitvogel, L., Halusczcak, K., Rabinowich, H., Duquesnoy, R., Storkus, W. J., & Lotze, M. T. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1681 · Cited by 155
Chang, W., Kim, J., Kim, Y., Kim, Y.-S., Lee, J.-M., Azuma, M., Yagita∥, H., & Kang, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6707 · Cited by 154
Won, E. J., Ju, J. K., Cho, Y., Jin, H., Park, K., Kim, T., Kwon, Y. S., Kee, H. J., Kim, J.-C., Kee, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11187 · Cited by 153
Jiang, J., Wang, X., An, H., Yang, B., Cao, Z., Liu, Y., Su, J., Zhai, F., Wang, R., Zhang, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0106oc · Cited by 151
Lamb, L. S., Henslee‐Downey, P. J., Parrish, R. S., Godder, K. T., THOMPSON, J. S., Lee, C. G., & Gee, A. P. (1996) · Journal of Hematotherapy · doi:10.1089/scd.1.1996.5.503 · Cited by 149
Lipid and small-molecule display by CD1 and MR1
Rhijn, I. V., Godfrey, D. I., Rossjohn, J., & Moody, D. B. (2015) · Nature reviews. Immunology · doi:10.1038/nri3889 · Cited by 148
Self-citationDulberger, C. L., McMurtrey, C., Hölzemer, A., Neu, K. E., Liu, V., Steinbach, A. M., García-Beltrán, W. F., Sulak, M. A., Jabrì, B., Lynch, V. J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.002 · Cited by 147
Ontogeny of human mucosal-associated invariant T cells and related T cell subsets
Youssef, G. B., Tourret, M., Salou, M., Ghazarian, L., Houdouin, V., Mondot, S., Mburu, Y. K., Lambert, M., Azarnoush, S., Diana, J., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171739 · Cited by 147
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
Wilhelm, M., Smetak, M., Schaefer‐Eckart, K., Kimmel, B., Birkmann, J., Einsele, H., & Kunzmann, V. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-45 · Cited by 145
Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
Chang, D., Deng, H., Matthews, P., Krasovsky, J., Ragupathi, G., Špíšek, R., Mazumder, A., Vesole, D. H., Jagannath, S., & Dhodapkar, M. V. (2008) · Blood · doi:10.1182/blood-2008-04-149831 · Cited by 143
Liu, Z., Eltoum, I. A., Guo, B., Beck, B. H., Cloud, G. A., & Lopez, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6044 · Cited by 142
High‐frequency and adaptive‐like dynamics of human CD1 self‐reactive T cells
de Lalla, C., Lepore, M., Piccolo, F. M., Rinaldi, A. M., Scelfo, A., Garavaglia, C., Mori, L., Libero, G. D., Dellabona, P., & Casorati, G. (2010) · European Journal of Immunology · doi:10.1002/eji.201041211 · Cited by 141
Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
Cordova, A., Toia, F., Mendola, C. L., Orlando, V., Meraviglia, S., Rinaldi, G., Todaro, M., Cicero, G., Zichichi, L., Donni, P. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049878 · Cited by 140
Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans
Metelitsa, L. S. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.10.005 · Cited by 139
Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy
Kunzmann, V., Smetak, M., Kimmel, B., et al. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318245bb1e · Cited by 139
αβ T cell antigen receptor recognition of CD1a presenting self lipid ligands
Birkinshaw, R. W., Pellicci, D. G., Cheng, T., Keller, A. N., Sandoval-Romero, M. L., Gras, S., de Jong, A., Uldrich, A. P., Moody, D. B., Godfrey, D. I., et al. (2015) · Nature Immunology · doi:10.1038/ni.3098 · Cited by 138
Self-citationZabijak, L., Attencourt, C., Guignant, C., Chatelain, D., Marcelo, P., Marolleau, J., & Treiner, E. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1764-7 · Cited by 136
Activating and Propagating Polyclonal Gamma Delta T Cells with Broad Specificity for Malignancies
Deniger, D. C., Maiti, S. N., Mi, T., Switzer, K. C., Ramachandran, V., Hurton, L. V., Ang, S., Olivares, S., Rabinovich, B. A., Huls, M. H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3451 · Cited by 134
Kasmar, A. G., Rhijn, I. V., Cheng, T., Turner, M. T., Seshadri, C., Schiefner, A., Kalathur, R., Annand, J. W., de Jong, A., Shires, J., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110665 · Cited by 132
Lança, T., Correia, D. V., Moita, C. F., Raquel, H., Neves‐Costa, A., Ferreira, C., Ramalho, J. S., Barata, J. T., Moita, L. F., Gomes, A. Q., et al. (2010) · Blood · doi:10.1182/blood-2009-08-237123 · Cited by 128
Type I natural killer T cells suppress tumors caused by p53 loss in mice
Swann, J. B., Uldrich, A. P., van Dommelen, S. L. H., Sharkey, J., Murray, W. K., Godfrey, D. I., & Smyth, M. J. (2009) · Blood · doi:10.1182/blood-2009-01-198564 · Cited by 126
Self-citationClinical and immunological aspects of HLA class I deficiency
Zimmer, J., Andrès, E., Donato, L., Hanau, D., Hentges, F., & de la Salle, H. (2005) · QJM · doi:10.1093/qjmed/hci112 · Cited by 126
Uldrich, A. P., Patel, O., Cameron, G., Pellicci, D. G., Clemens, E. B., Sullivan, L. C., Kyparissoudis, K., Kjer‐Nielsen, L., Vivian, J. P., Cao, B., et al. (2011) · Nature Immunology · doi:10.1038/ni.2051 · Cited by 122
Self-citationUssher, J. E., Willberg, C. B., & Klenerman, P. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12008 · Cited by 118
Bennouna, J., Lévy, V., Sicard, H., Senellart, H., AUDRAIN, M. A. P., Hiret, S., Rolland, F., Bruzzoni‐Giovanelli, H., Rimbert, M., Galéa, C., et al. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0879-0 · Cited by 117
Nicol, A. J., Nieda, M., Koezuka, Y., Porcelli, S. A., Suzuki, K., Tadokoro, K., Durrant, S., & Juji, T. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00952.x · Cited by 117
Shared and Distinct Phenotypes and Functions of Human CD161++ Vα7.2+ T Cell Subsets
Kurioka, A., Jahun, A. S., Hannaway, R. F., Walker, L. J., Fergusson, J. R., Sverremark‐Ekström, E., Corbett, A. J., Ussher, J. E., Willberg, C. B., & Klenerman, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01031 · Cited by 117
Galactose‐modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis
Aspeslagh, S., Li, Y., Yu, E. D., Pauwels, N., Trappeniers, M., Girardi, E., Decruy, T., Beneden, K. V., Venken, K., Drennan, M. B., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.145 · Cited by 115
CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens
Ly, D., Kasmar, A. G., Cheng, T., de Jong, A., Huang, S., Roy, S., Bhatt, A., van Summeren, R. P., Altman, J. D., Jacobs, W. R., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20120624 · Cited by 115
Bouet-Toussaint, F., Cabillic, F., Toutirais, O., Gallo, M. L., Pintière, C. T. D. L., Daniel, P., Genetet, N., Meunier, B., Dupont-Bierre, E., Boudjéma, K., et al. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0391-3 · Cited by 114
Clinical Applications of Gamma Delta T Cells with Multivalent Immunity
Deniger, D. C., Moyes, J. S. E., & Cooper, L. J. N. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00636 · Cited by 113
Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction
Brennan, P. J., Tatituri, R. V. V., Heiß, C., Watts, G. F. M., Hsu, F., Veerapen, N., Cox, L. R., Azadi, P., Besra, G. S., & Brenner, M. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415357111 · Cited by 112
Gherardin, N. A., Loh, L., Admojo, L., Davenport, A. J., Richardson, K., Rogers, A. J., Darcy, P. K., Jenkins, M. R., Prince, H. M., Harrison, S. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22130-1 · Cited by 111
Self-citationNishikawa, H., Kato, T., Tawara, I., Takemitsu, T., Saito, K., Wang, L., Ikarashi, Y., Wakasugi, H., Nakayama, T., Taniguchi, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503852102 · Cited by 110
A novel self-lipid antigen targets human T cells against CD1c+ leukemias
Lepore, M., de Lalla, C., Gundimeda, S., Gsellinger, H., Consonni, M., Garavaglia, C., Sansano, S., Piccolo, F. M., Scelfo, A., Häußinger, D., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140410 · Cited by 109
Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2
Lampen, M. H., Hassan, C., Sluijter, M., Geluk, A., Dijkman, K., Tjon, J. M. L., de Ru, A. H., van der Burg, S. H., van Veelen, P. A., & van Hall, T. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.07.009 · Cited by 107
Howson, L. J., Napolitani, G., Shepherd, D., Ghadbane, H., Kurupati, P., Preciado‐Llanes, L., Rei, M., Dobinson, H., Gibani, M. M., Teng, K. W. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02540-x · Cited by 107
Wada, I., Matsushita, H., Noji, S., Mori, K., Yamashita, H., Nomura, S., Shimizu, N., Seto, Y., & Kakimi, K. (2014) · Cancer Medicine · doi:10.1002/cam4.196 · Cited by 106
Yazdi, M. T., van Riet, S., van Schadewijk, A. M., Fiocco, M. F., van Hall, T., Taube, C., Hiemstra, P. S., & van der Burg, S. H. (2015) · Oncotarget · doi:10.18632/oncotarget.6506 · Cited by 105
Liu, Z., Guo, B., Gehrs, B. C., Nan, L., & Lopez, R. D. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000154355.45816.0b · Cited by 103
The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects
Oliveira, C., van Veelen, P. V., Querido, B. J., de Ru, A. H., Sluijter, M., Laban, S., Drijfhout, J., van der Burg, S., Offringa, R., & van Hall, T. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091429 · Cited by 101
Péterfalvi, Á., Gömöri, É., Magyarlaki, T., Pál, J., Bánáti, M., Javorhazy, A., Szekeres‐Barthó, J., Szereday, L., & Illés, Z. (2008) · International Immunology · doi:10.1093/intimm/dxn111 · Cited by 100
Gillessen, S., Naumov, Y. N., Nieuwenhuis, E. E. S., Exley, M. A., Lee, F. S., Mach, N., Luster, A. D., Blumberg, R. S., Taniguchi, M., Balk, S. P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1033098100 · Cited by 100
Lower TCR repertoire diversity in Traj18-deficient mice
Bedel, R., Matsuda, J. L., Brigl, M., White, J., Kappler, J. W., Marrack, P., & Gapin, L. (2012) · Nature Immunology · doi:10.1038/ni.2347 · Cited by 97
γδ T Cells: Unexpected Regulators of Cancer Development and Progression
Fleming, C., Morrissey, S. M., Cai, Y., & Yan, J. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.06.003 · Cited by 97
Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases
Joosten, S. A., Sullivan, L. C., & Ottenhoff, T. H. M. (2016) · Journal of Immunology Research · doi:10.1155/2016/2695396 · Cited by 96
Takeuchi, A., Dejima, T., Yamada, H., Shibata, K., Nakamura, R., Eto, M., Nakatani, T., Naito, S., & Yoshikai, Y. (2010) · European Journal of Immunology · doi:10.1002/eji.201040773 · Cited by 95
Aberrant human leucocyte antigen‐G expression and its clinical relevance in hepatocellular carcinoma
Lin, A., Chen, H. ‐., Zhu, C., Zhang, X., Xu, H., Zhang, J. ‐., Wang, Q., Zhou, W., & Yan, W. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00917.x · Cited by 91
Izumi, T., Kondo, M., Takahashi, T., Fujieda, N., Kondo, A., Tamura, N., Murakawa, T., Nakajima, J., Matsushita, H., & Kakimi, K. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2012.12.004 · Cited by 86
A new mouse strain for the analysis of invariant NKT cell function
Chandra, S., Zhao, M., Budelsky, A., Pulido, Á. D. M., Day, J., Fu, Z., Siegel, L. A., Smith, D. E., & Kronenberg, M. (2015) · Nature Immunology · doi:10.1038/ni.3203 · Cited by 85
Křen, L., Slabý, O., Múčková, K., Lžičařová, E., Sova, M., Vybíhal, V., Svoboda, T., Fadrus, P., Lakomý, R., Vaňhara, P., et al. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2010.01149.x · Cited by 84
NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
Anderson, R. J., Compton, B. J., Tang, C., Authier-Hall, A., Hayman, C. M., Swinerd, G. W., Kowalczyk, R., Harris, P. W. R., Brimble, M. A., Larsen, D. S., et al. (2015) · Chemical Science · doi:10.1039/c4sc03599b · Cited by 81
T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids
Wun, K. S., Reijneveld, J. F., Cheng, T., Ladell, K., Uldrich, A. P., Nours, J. L., Miners, K. L., McLaren, J. E., Grant, E. J., Haigh, O. L., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0065-7 · Cited by 80
Self-citationShaler, C. R., Tun‐Abraham, M. E., Skaro, A. I., Khazaie, K., Corbett, A. J., Mele, T. S., Hernandez‐Alejandro, R., & Haeryfar, S. M. M. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2050-7 · Cited by 79
Kawashima, T., Norose, Y., Watanabe, Y., Enomoto, Y., Narazaki, H., Watari, E., Tanaka, S., Takahashi, H., Yano, I., Brenner, M. B., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5345 · Cited by 77
In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma
Pressey, J. G., Adams, J. M., Harkins, L. E., Kelly, D. R., You, Z., & Lamb, L. S. (2016) · Medicine · doi:10.1097/md.0000000000004909 · Cited by 77
Kobayashi, H., Tanaka, Y., Shimmura, H., Minato, N., & Tanabe, K. (2010) · PubMed · Cited by 72
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis
Gorini, F., Azzimonti, L., Delfanti, G., Scarfò, L., Scielzo, C., Bertilaccio, M. T. S., Ranghetti, P., Gulino, A., Doglioni, C., Napoli, A. D., et al. (2017) · Blood · doi:10.1182/blood-2016-11-751065 · Cited by 72
Taraban, V. Y., Martin, S., Attfield, K. E., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4615 · Cited by 71
iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells
Bellone, M., Ceccon, M., Grioni, M., Jachetti, E., Calcinotto, A., Napolitano, A., Freschi, M., Casorati, G., & Dellabona, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008646 · Cited by 71
Cited by
Cancer immunoediting and resistance to T cell-based immunotherapy
O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Self-citationHarnessing innate immunity in cancer therapy
Demaria, O., Cornen, S., Daëron, M., Morel, Y., Medzhitov, R., & Vivier, E. (2019) · Nature · doi:10.1038/s41586-019-1593-5 · Cited by 957
The biology and functional importance of MAIT cells
Godfrey, D. I., Koay, H.-F., McCluskey, J., & Gherardin, N. A. (2019) · Nature Immunology · doi:10.1038/s41590-019-0444-8 · Cited by 581
Self-citationGuidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Self-citation
Metadata
- Authors
- Godfrey, D. I., Le Nours, J., Andrews, D. M., Uldrich, A. P., & Rossjohn, J.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 48
- Issue
- 3
- Pages
- 453-473
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2791034815
- Cited by
- 314
- References
- 248
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.